2016 Confirmed Speakers

Yasmina Abdiche, Ph.D., Research Fellow; Head, Bioanalytics Group, Rinat-Pfizer

Gregory Adams, Ph.D., Chief Development Officer, Viventia Bio

Meera Agarkhed, Manager, Formulation Development, Eli Lilly and Company

Jonathan Alvarez, Research Associate II, Crystalomics, Althea

Arna Andrews, Ph.D., Director, Cell Line Development, CSL Limited

Valentyn Antochshuk, Ph.D., Principal Scientist, Bioprocess Development, Merck

Zahir Akhunzada, Ph.D., Research Scientist, ABD, Bristol-Myers Squibb

Alptekin Aksan, Ph.D., Associate Professor, Mechanical Engineering, University of Minnesota

Alina A. Alexeenko, Ph.D., Associate Professor, School of Aeronautics and Astronautics, Purdue University

Carlos J. Alméciga-Díaz, Ph.D., BPharm, Associate Professor, Institute for the Study of Inborn Errors of Metabolism (IEIM), School of Sciences, Pontificia Universidad Javeriana

Richard Altman, MS, Research Scientist, Discovery Research, Alexion Pharmaceuticals

Andreas Anton, Director, BioProcess Development, Wacker Biotech GmbH

Michael Antoniou, Ph.D., Research Group Leader, Medical & Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London

Susan Babuka, Senior Formulation Scientist, XOMA Corp.

Yun Bai, Ph.D., Director, Process Development, Ambrx, Inc.

Gavin Barnard, Ph.D., Group Leader, Eli Lilly and Company

Elizabeth Bartlett, Scientist II, Analytical & Pharmaceutical Sciences, ImmunoGen, Inc.

Deniz Baycin Hizal, Ph.D., Scientist II, Antibody Discovery & Protein Engineering, MedImmune

Christian Bender, Ph.D., Computational Biologist, Antibody Lead Discovery, Bayer HealthCare

Lawrence Berliner, Ph.D., Professor of Chemistry and Biochemistry, University of Denver; Emeritus, Ohio State University

 Matthew J. Bernett, Ph.D., Senior Scientist, Protein Engineering, Xencor, Inc.

Ruben Boado, Ph.D., Vice President, R&D, ArmaGen, Inc.

Robin Bogner, Ph.D., Associate Professor, Pharmaceutical Sciences, School of Pharmacy, University of Connecticut

Julie Bonvin, Ph.D., Lead, Analytical Development Group, Glenmark Pharmaceuticals, Switzerland

Mark Brader, Ph.D., Principal Scientist, Protein Pharmaceutical Development, Biogen

Mark Branum, Ph.D., Director, Theraclone

Jeffery Breit, Ph.D., Director, Biologic Technologies, Bend Research, a division of Capsugel

Randall Brezski, Ph.D., Scientist, Antibody Engineering, Genentech

Russell Burge, Applications Scientist, Freeslate

Nicola Burgess-Brown, Ph.D., Principal Investigator, Biotechnology, Structural Genomics Consortium (SGC), University of Oxford

Susan Callahan, Scientist, Amgen, Inc.

Edith Chang, Ph.D., Scientific Liaison, Biologics and Biotechnology, US Pharmacopeia

 Ravi J. Chari, Ph.D., Vice President, Chemistry & Biochemistry, ImmunoGen, Inc.

Gang Chen, Ph.D., Executive Director, Protein Expression Sciences, Regeneron Pharmaceuticals, Inc.

JrGang Cheng, Ph.D., Associate Professor, The Neuroscience Center, University of North Carolina at Chapel Hill

Henry C. Chiou, Ph.D., Associate Director, Cell Biology, Life Science Solutions, Thermo Fisher Scientific

Mark Chiu, Ph.D., Principal Scientist, Multispecific Biologics Engineering, Janssen Biotechnology

Danny Chou, Ph.D., former Senior Research Scientist, Biologics Development, Gilead Sciences; President and Founder, Compassion BioSolution

Partha Chowdhury, Ph.D., Principal Scientist, MedImmune

Jennifer Cochran, Ph.D., The Hitachi America Associate Professor, Bioengineering, and Chemical Engineering Director, Graduate Studies, Stanford University

Caroline Colley, Ph.D., Senior Scientist, Antibody Discovery and Protein Engineering, MedImmune, United Kingdom

Samuel Coulbourn Flores, Ph.D., Assistant Professor, Cell and Molecular Biology, Uppsala University, Sweden

Yongping Crawford, Ph.D., Scientist, Early Stage Cell Culture, Genentech, Inc., a member of the Roche Group

Joseph E. Curtis, Ph.D., Research Chemist, Condensed Matter Science Group, NIST Center for Neutron Research, National Institute of Standards and Technology

Abhishek Datta, Ph.D., Scientist II, Drug Discovery, Biogen

Matthew P. DeLisa, Ph.D., William L. Lewis Professor, Chemical & Biomolecular Engineering, Cornell University

Luc R. Desnoyers, Ph.D., Director, Oncology, CytomX Therapeutics, Inc.

Roberto DePaz, Ph.D., Senior Scientist, Biopharmaceutical Development, MedImmune

Michael DiFiore, Scientist I, Materials Science, Bristol-Myers Squibb

Dimiter S. Dimitrov, Ph.D., Senior Investigator, Protein Interaction Group, FNLCR, NCI, National Institute of Health

Rakesh Dixit, Ph.D., DABT, Vice President, Research & Development, and Global Head, Biologics Safety Assessment, MedImmune

Peter Dragovich, Ph.D., Principal Scientist, Medicinal Chemistry, Genentech, Inc., a member of the Roche Group

Zhimei Du, Ph.D., Senior Principal Scientist & Head, Cell Line Development, Merck

Peter Ellmark, Ph.D., Principal Scientist, Research, Alligator Bioscience AB, Sweden

Greg Elson, Ph.D., Vice President, Biologics Manufacturing, Glenmark Pharmaceuticals

Alan L. Epstein, M.D., Ph.D., Professor, Pathology, University of Southern California Keck School of Medicine

James Ernst, Ph.D., Senior Scientist, Protein Therapeutics, Genentech, Inc., a member of the Roche Group

Dominic Esposito, Ph.D., Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.

Joachim Feldwisch, Ph.D., Director, Preclinical Development, Affibody AB

Fortunato Ferrara, Ph.D., Research Assistant Professor, Experimental Therapeutics University of New Mexico

Jeffrey Fishpaugh, Ph.D., Senior Principal Research Scientist, Diagnostic Analytical Chemistry R&D, Abbott Laboratories

Bernard A. Fox, Ph.D., Harder Family Chair and Chief, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Providence Cancer Center

Jeremy Fry, D.Phil., Sales, Director, ProImmune Ltd.

Yanwen Fu, Ph.D., Associate Director, Antibody Technologies and Chemical Biology, Sorrento Therapeutics

Shyra J. Gardai, Ph.D., Principal Scientist, Immunology, Seattle Genetics

Melissa Geddie, Ph.D., Principal scientist, Discovery, Merrimack Pharma

Avinash Gill, Ph.D., Scientific Manager, Antibody Engineering, Genentech, Inc., a member of the Roche Group

William Gillette, Ph.D., Senior Scientist, Protein Expression Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research (FNL)

Pierre-Alain Girod, Ph.D., CSO, Selexis SA

James Giulianotti, Senior Research Associate, Early Stage Cell Culture, Genentech, Inc.

Anton Glieder, Ph.D., Professor, Molecular Biotechnology, Graz University of Technology

Ulrich Goepfert, Ph.D., Principal Scientist, Cell Line & Molecular Development, Roche Innovation Center Penzberg

Susanne Gräslund, Ph.D., Principal Investigator, Structural Genomics Consortium, Medical Biochemistry and Biophysics, Karolinska Institute

Felix Hart, MSc, Scientist, Bioassays & Nonclinical Studies, Glycotope GmbH

John Haurum, M.D., D.Phil., CEO, F-star GmbH & F-star Biotechnology Ltd., United Kingdom

Partha Hazra, Ph.D., Chief Scientific Manager, Research, Biocon

Mary J. Hinrichs, Ph.D., Principal Toxicologist, Biologics Safety Assessment, MedImmune

Jonas Hoeg Thygesen, Ph.D., Research Scientist, R&D - Microanalysis Centre, Novo Nordisk Pharmatech

Sean Hu, Ph.D., Senior Vice President, R&D, Dophen Biomed

Gregory C. Ippolito, Ph.D., Research Assistant Professor, Molecular Biosciences, The University of Texas at Austin

Alexander Ivanov, Ph.D., Senior Scientist, AbbVie Bioresearch Center

Nina Jain, Research Associate, Alexion Pharmaceuticals

Alexander Jarasch, Ph.D., Bioinformatics Scientist, Pharma Research and Early development, Therapeutic Modalities, Roche Innovation Center Penzberg, Roche

Dennis Jenke, Ph.D., Baxter Distinguished Scientist, Technology Resources, Baxter Healthcare Corp.

Jan Jezek, Ph.D., CSO, Development, Arecor Ltd.

Jian-Ping Jin, M.D., Ph.D., Professor and William D. Traitel Endowed Chair, Physiology, Wayne State University School of Medicine

Marisa K. Joubert, Ph.D., Senior Scientist, Process & Product Development, Amgen, Inc.

H. Ronald Kaback, M.D., Distinguished Professor, Physiology, University of California, Los Angeles

Bogumil J. Karas, Ph.D., Adjunct Scientist, Department of Synthetic Biology and Bioenergy, J. Craig Venter Institute; Founder & CSO, Designer Microbes Inc.

Madan Katragadda, Ph.D., Senior Principal Scientist, Pfizer

Christopher W. Kemp, Ph.D., President, Kempbio, Inc.

Tarik Khan, Ph.D., Postdoctoral Fellow, Late-Stage Pharmaceutical and Processing Development, F. Hoffmann-La Roche Ltd., Switzerland

Nikolai Khramtsov, Ph.D., Associate Director, Upstream Development, Process Development, Protein Sciences Corp.

Kyu-Tae Kim, Ph.D., Director, ADDs Program, AbClon

Philip M. Kim, Ph.D., Associate Professor, Computational and Integrative Biology, University of Toronto, Canada

Marina Kirkitadze, Ph.D., MBA, Deputy Director, Analytical R&D Biochemistry, Sanofi Pasteur

Shohei Koide, Ph.D., Professor, Biochemistry and Molecular Biology, University of Chicago

Harald Kolmar, Ph.D., Professor and Head, Applied Biochemistry, Chemistry, Technical University of Darmstadt

Denise Krawitz, Ph.D., Senior Manager, Analytical Operations, Genentech, Inc.

Oliver Krieter, M.D., Senior Translational Medicine Leader, pRED Innovation Center Penzberg, Roche Pharma Research and Early Development

Zephania Kwong Glover, MSc, Senior Research Associate, Late Stage Pharmaceutical Development, Genentech, Inc.

Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire

Scott Lesley, Ph.D., Director, Protein Sciences and Biotherapeutics, The Genomics Institute of the Novartis Research Foundation & the Scripps Research Institute

Nathan E. Lewis, Ph.D., Assistant Professor, Department of Pediatrics, University of California, San Diego

Kim Li, Ph.D., DABT, MPH, Senior Manager, Environment, Health, Safety and Sustainability, Amgen, Inc.

Konstantin M. Linnik, Ph.D., Partner, Intellectual Property, Nutter, McClennen & Fish, LLP

James D. Love, Ph.D., Director, Technology Development & Research Assistant Professor, Biochemistry, Albert Einstein College of Medicine

Kelly Loyet, Ph.D., Scientist, Biochemical and Cellular Pharmacology, Research, Genentech, Inc.

Ling Lu, Senior Principal Scientist, Design Controls, Pharmaceutical Research and Development, Biotherapeutic Pharmaceutical Sciences, Pfizer

Patrick Lupardus, Ph.D., Scientist, Structural Biology, Genentech, Inc.

Robert Mabry, Ph.D., Director, Protein Sciences and Antibody Technology, Jounce Therapeutics

Tarun Mandal, Ph.D., McCaffrey/Norwood Endowed Professor of Pharmacy & Director, Center for Nanomedicine & Drug Delivery, College of Pharmacy, Xavier University of Louisiana

Mark Manning, Ph.D., CSO, Legacy BioDesign LLC

Radhakrishna K. Maroju, Ph.D., Scientist, CMC Management, Drug Product Development, Teva Biopharmaceuticals USA

Yariv Mazor, Ph.D., Scientist, Antibody Discovery and Protein Engineering, MedImmune, LLC

Kathryn A. McGohan, MS, Associate Scientist II, Manufacturing Sciences and Technology: Materials Science, Bristol-Myers Squibb

James Meador, Senior Scientist, Protein Expression and Purification Group, Research Department, Momenta Pharmaceuticals, Inc.

Colin Medley, Ph.D., Scientist, Genentech

Michela Silacci Melkko, Ph.D., Director, Discovery Research, Covagen AG, one of the Janssen Pharmaceutical Companies of J&J

Nico Mertens, Ph.D., Vice President and Head, Antibody Research, R&D, Biotecnol, Ltd.

Céline Monnet, Ph.D., Senior Scientist, Molecular Design Unit, Innovation Department, LFB Biotechnologies

Susmith Mukund, Senior Research Associate, Genentech

Auayporn P. Nademanee, M.D., Jan & Mace Siegel Professor, Hematology & Hematopoietic Cell Transplantation, Associate Clinical Director, Hematology & Hematopoietic Cell Transplantation, and Director, Matched Unrelated Donor (MUD) Program, City of Hope

Mikiko Nakamura, Ph.D., Research Fellow, Department of Applied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University　　

Yasser Nashed-Samuel, Ph.D., Principal Scientist, Process and Product Development, Amgen, Inc.

Vishal C. Nashine, Ph.D., Senior Research Investigator, Drug Product Science & Technology, Bristol-Myers Squibb Co.

Juergen Nett, Ph.D., Associate Director, High Throughput Expression, Adimab, LLC

Lars Keld Nielsen, Ph.D., Chair & Professor, Biological Engineering, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland

Ahuva Nissim, Ph.D., Reader, Antibody and Therapeutic Engineering, Biochemical Pharmacology, Queen Mary University

Stanley Opella, Ph.D., Professor, Chemistry and Biochemistry, University of California, San Diego

Joe Orlando, Ph.D., Head, Molecular Biology and Protein Expression, Process Solutions, EMD Millipore Corporation

Peter U. Park, Ph.D., Vice President, Biology, Mersana Therapeutics, Inc.

Paul W.H.I. Parren, Ph.D., Senior Vice President and Scientific Director, Genmab, The Netherlands

Henrik Rajesh Kumar Parshad, Ph.D., Principal Scientist, Biopharm Formulation Development, Novo Nordisk A/S

Diane Paskiet, MS, Director of Scientific Affairs, West Pharmaceutical

Sajal M. Patel, Ph.D., Senior Scientist, Formulation Sciences, Biopharmaceutical Development, MedImmune, Inc.

Sanket Patke, Ph.D., Research Investigator, Drug Product Science and Technology, Pharmaceutical Development, Bristol-Myers Squibb

Michael Pikal, Ph.D., Distinguished Endowed Chair in Pharmaceutical Technology & Professor of Pharmaceutics, University of Connecticut

Guy G. Poirier, Ph.D., Professor, Biochemistry, and Canada Chair, tier1 in Proteomics and PROTEO, CHU de Québec Research Center, Laval University

Shashi Prajapati, Ph.D., Senior Scientist, Biogen

Ken K. Qian, Ph.D., Research Chemist and NIST-MedImmune Fellow, Biomaterials Group, National Institute of Standards and Technology

Sergio A. Quezada, Ph.D., Professorial Research Fellow, UCL Cancer Institute, United Kingdom

Christoph Rader, Ph.D., Associate Professor, Cancer Biology and Molecular Therapeutics, The Scripps Research Institute

Ginger Chao Rakestraw, Ph.D., Senior Research Investigator II, Bristol-Myers Squibb

Vladimir Razinkov, Ph.D., Principal Scientist, Product Formulation Technologies Amgen

Wayne F. Reed, Ph.D., Murchison Mallory Chair Professor of Physics and Founding Director, PolyRMC, Tulane University

Jörg Thomas Regula, Ph.D., Head, Functional Characterization, Large Molecule Research, Roche Pharma Research & Early Development

Norbert O. Reich, Ph.D., Professor, Chemistry & Biochemistry, University of California, Santa Barbara

Dietmar Reusch, Ph.D., Director, Development Characterization, Pharma Biotech Production and Development, Roche Diagnostics GmbH

Joël Richard, Ph.D., Senior Vice President Peptides, Technical Operations, Ipsen

Dean Ripple, Ph.D., Leader, Bioprocess Measurements Group, National Institute of Science and Technology

Patrick Robertson, Ph.D., Senior Scientist, Purification Development, FUJIFILM Diosynth Biotechnologies

Thomas Robinson, M.D., Managing Director, Corporate, Aerosol Therapeutics, LLC

Brooke Rock, Ph.D., Senior Scientist, Pharmacokinetics and Drug Metabolism, Amgen, Inc.

Michael Rosenzweig, DVM, Ph.D., Executive Director, Immuno-oncology, Merck Research Laboratories

Pauline M. Rudd, Ph.D., Research Professor, Glycobiology, National Institute for Bioprocessing Research and Training (NIBRT)

Sarah Rue, Ph.D., Senior Research Investigator, Genomics Institute of the Novartis Research Foundation (GNF)

Shawn Russell, Ph.D., Associate Director, Process Development, Five Prime Therapeutics

Ramkrishna (Ramu) Sadhukhan, Senior Group Leader, AbbVie Bioresearch Center Center

Atul Saluja, Ph.D., Senior Research Investigator II, Drug Product Science & Technology, Bristol-Myers Squibb

Divya Samineni, Ph.D., Clinical Pharmacologist, Antibody Drug Conjugates, Genentech, Inc., a member of the Roche Group

Hardeep Samra, Ph.D., Senior Scientist, Formulation Sciences, MedImmune

Marinella Sandros, Ph.D., Assistant Professor, Department of Nanoscience, University of North Carolina at Greensboro

Aaron K. Sato, Ph.D., Vice President, Research, Sutro Biopharma, Inc.

Jonas V. Schaefer, Ph.D., Head, High-Throughput Laboratory, University of Zurich

Mathias Schaffrath, Ph.D., LGCR Chemistry, Library and Peptide Purification, Sanofi-Aventis Deutschland GmbH

David A. Scheinberg, M.D., Ph.D., Vincent Astor Chair, and Chairman, Molecular Pharmacology Program, Sloan Kettering Institute

Tilman Schlothauer, Ph.D., Senior Scientist, Biochemical and Analytical Research, Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Penzberg, Germany

Stefan Schmidt, Ph.D., MBA, Vice President, Process Science and Production, Rentschler Biotechnology

Michael Schopperle, Ph.D., CEO, CureMeta

Lynette Schroeter, Lead Associate Scientist, Crystalomics, Althea

Jim Searles, Ph.D., Technical Fellow, Global Manufacturing Science and Technology, Hospira

Peter Senter, Ph.D., Vice President, Chemistry, Seattle Genetics, Inc.

Evgenyi Shalaev, Ph.D., Research Investigator, Pharmaceutical Development, Allergan Inc.

Wei-Chiang Shen, Ph.D., John A. Biles Professor, Pharmacology & Pharmaceutical Sciences, University of Southern California

Joseph Shiloach, Ph.D., Head, Biotechnology Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health

Eric Shusta, Ph.D., Professor, Chemical and Biological Engineering, University of Wisconsin

Christopher Smith, Ph.D., CSO, Biologics

Richard Smith, Ph.D., Director of Research, Amgen, Inc.

Dan Some, Ph.D., Principal Scientist, Marketing, Wyatt Technology

Paul M. Sondel, M.D., Ph.D., Professor, Pediatrics, Hematology & Oncology, University of Wisconsin, Madison

Christoph Spiess, Ph.D., Senior Scientist, Antibody Engineering, Genentech, Inc., a member of the Roche Group

Dirk Spitzer, Ph.D., Instructor, Surgery, Washington University School of Medicine

Patrik Strömberg, Ph.D., Head, Biomedical Science and Portfolio Innovation, Swedish Orphan Biovitrum AB (SOBI)

Shantanu Sule, Ph.D., Senior Engineer, Protein Drug Product & Device Development, Biogen

Laura Sun, Ph.D., Principle Research Associate, Translational Oncology, Genentech, Inc.

Mohammad Tabrizi, Ph.D., Head, PK/PD & Senior Fellow, Merck Research Laboratories Palo Alto

Sonia Taktak, Ph.D., Analytical Scientist III, Analytical and Pharmaceutical Sciences, ImmunoGen, Inc.

Janice Tan, Ph.D., Research Scientist, Bioprocessing Technology Institute, A*STAR

Charlie (Xiaolin) Tang, Ph.D., Director, Formulation Development, Regeneron Pharmaceuticals, Inc.

Yuri Teranishi, Researcher, Antibody Engineering Group, Discovery Research, Chugai Pharmaceutical Co., Ltd., Japan

Tharmala Tharmalingam, Ph.D., Scientist, Process and Product Development, Amgen, Inc.

Geetha Thiagarajan, Ph.D., Associate Principal Scientist, Sterile Product and Analytical Development, Merck

Taylor Thompson, President, Millrock Technology, Inc.

Nels Thorsteinson, Scientific Services Manager, Biologics, Chemical Computing Group

Jens Thostrup Bukrinski, Ph.D., Senior Scientist, Biopharma Research and Development, Novozymes A/S

Andrea Throop, Ph.D., Production Manager, Center for Personalized Diagnostics, Biodesign Institute, Arizona State University

Feng Tian, Ph.D., Chief Scientific Officer, Ambrx, Inc.

Miller Tran, Ph.D., Senior Scientist, Lead Discovery, Verdant Therapeutics, Inc.

Daniëlle van Wijk, Ph.D., Lead Scientist / Project Leader, Down Stream Processing, Synthon Biopharmaceuticals B.V.

Gayathri Vasudevan, Ph.D., Associate Principal Scientist, Analytical and Formulations Development, FUJIFILM Diosynth Biotechnologies

David Vikström, Ph.D., CTO, Xbrane Bioscience

Renaud Vincentelli, Ph.D., Head, Protein Production, Structural Biology Facility, AFMB, CNRS University Aix Marseille

Tom Vink, Ph.D., Associate Director, Cell & Molecular Science, Genmab BV

Bjørn Voldborg, MSc, Director, CHO Cell Line Development, Novo Nordisk Foundation Center for Biosustainability (CFB), DTU Biosustain, Technical University of Denmark

David B. Volkin, Takeru and Aya Higuchi Distinguished Professor of Pharmaceutical Chemistry. The University of Kansas School of Pharmacy

Per-Olof Wahlund, Ph.D., Senior Scientist, Biophysics Screening & Characterization Novo Nordisk, Denmark

Kenneth Walker, Ph.D., Scientific Director, Biologics, Amgen, Inc.

Pramila Walpita, Ph.D., Assistant Professor, Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa

Bingquan (Stuart) Wang, Ph.D., Senior Scientist, Biogen

Y. John Wang, Ph.D., Principal Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.

E. Sally Ward, Ph.D., Professor, Molecular and Cellular Medicine, Texas A&M Health Science Center

Trevor Wattam, Ph.D., Manager, Biopharm Discovery Group, Biopharm Discovery Group, GlaxoSmithKline

Robert O.J. Weinzierl, Ph.D., Reader, Molecular Biology, Life Sciences, Imperial College London

Mark Welch, Vice President, Research and Development, DNA2.0 Inc.

Ann White, Ph.D., Cancer Sciences Unit, Southampton University, United Kingdom

Paul Widboom, Ph.D., Senior Scientist, Antibody Engineering, Adimab LLC

Ken Wong, Deputy Director, MTech/AP&T - Extractables & Leachables, Sanofi Pasteur

David Wood, Ph.D., Associate Professor, Chemical & Biomolecular Engineering, The Ohio State University

Carsten Worsøe, Principal Scientist, Novo Nordisk A/S

Jiansheng Wu, Ph.D., Senior Scientist, Protein Chemistry, Genentech, Inc.

Mateusz Wydro, Ph.D., Principal Scientist, Protein Sciences, F-star Biotechnology, Ltd.

Nina Xiao, Ph.D., Senior Research Associate, Late Stage Pharmaceutical Development, Genentech, Inc.

Han Xu, Ph.D., Principal Scientist, Amgen, Inc.

Sandeep Yadav, Ph.D., Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.

Jihong Yang, Ph.D., Senior Scientist, Bioanalytical Sciences, Genentech, Inc.

Jiing-Kuan Yee, Ph.D., Professor, Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center

Ping Y. Yeh, Ph.D., Executive Director, Drug Product Formulation Technologies, Process Development, Amgen Inc.

Alexei Yeliseev, Ph.D., Staff Scientist, LMBB, NIH/ NIAAA

Stefan Zahn, Ph.D., Principal Scientist, Antibody Technology, Novo Nordisk A/S, Sweden

Ali Zarrin, Ph.D., Scientist, Immunology, Genentech

Larry Zeitlin, Ph.D., President, Mapp Biopharmaceutical and LeafBio, Inc.

Green Guihang Zhang, Ph.D., Director, Protein Sciences, ImaginAb, Inc.

Zhongqi Zhang, Ph.D., Scientific Director, Amgen, Inc.

Liangyi Zhang, Ph.D., Senior Scientist II, Process Sciences, Abbvie

Silvia Zucchelli, Ph.D., Assistant Professor, University of Eastern Piedmont, UPO; CSO, TransSINE Technologies